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Sıçan farklı beyin bölgelerinde M1 muskarinik reseptör alt tipi seviyeleri
ÖZ
Amaç: Travma sonrası stres bozukluğu (TSSB) yaşamı tehdit eden 
travma, aşırı uyarılma, flashbackler ve kabuslar ile karakterizedir. 
TSSB araştırmaları, travmatik bir deneyimin beyinin davranış 
ve işlevleri üzerinde uzun süreli bozulma etkilerine yol açtığını 
anlamanın zorluğuyla karşı karşıyadır. Herhangi bir spesifik ajanın 
etkinliğini destekleyecek uygun kanıt olmadığında, TSSB’nin 
farmakoterapisinde birçok farmakolojik ajan kullanılmaktadır. 
Olumsuz bir deneyimin geri çağrılmasında M
1 
muskarinik reseptör 
alt tiplerinin önemli rol oynayabileceği öngörülmektedir. Bu 
araştırmanın amacı, TSSB’de kronik fluoksetin (FLU) (2.5 mg/
gün; i.p) tedavisinin hem davranışsal hem de moleküler etkinliğini 
ve farmakoterapinin sıçanlarda M
1 
muskarinik reseptör alt tipi 
ekspresyonu üzerine muhtemel etkisini araştırmaktır.
Gereç ve Yöntem: Deney tasarımında tüm gruplar rastgele 
olarak seçilerek Kontrol, Stres ve Tedavi grupları oluşturulmuştur. 
Kronik FLU tedavisinin etkileri, sıçan hipokampüs ve frontal 
korteksinde, M
1 
reseptörlerinin ekspresyon seviyeleri açısından 
değerlendirilmiştir.
Bulgular: Sıçanlar deneyin son gününde (30.Gün) travma 
hatırlatıcılara maruz kaldıklarında, stres gruplarındaki anksiyete 
indekslerinin kontrol grubuna göre belirgin bir şekilde arttığı 
gözlemlenmiştir (P<0.001). Ayrıca, kronik FLU tedavisinin stress 
gruplarında anksiyete değerlerini düşürerek geriye döndürdüğü 
gözlemlenmiştir (P<0.001).
Sonuç: Bu çalışmada, stresin kaygı benzeri davranışları 
arttırarak sıçan beyin hipokampüs ve frontal korteksinde M
1 
ekspresyon seviyesini azalttığı gözlemlenmiştir. Düşük doz 
kronik FLU tedavisi ile bu etkilerin geri döndürülebileceği 
öngörülmektedir.
Anahtar kelimeler: Muskarinik reseptör, Stres, Kedi kumu, 
Fluoksetin, Hippokampüs, Frontal korteks
Introduction
Post-traumatic stress disorder (PTSD) is characterized by 
overexcitation, flashbacks and nightmares that leads to 
ABSTRACT
Objectives: Post-traumatic stress disorder (PTSD) is characterized 
by life threatening trauma, overexcitation, flashbacks and 
nightmares. Research on PTSD is faced with the challenge of 
understanding how a traumatic experience leads to long lasting 
detrimental effects on behavior and functions of the brain. Many 
pharmacological agents are available in the pharmacotherapy 
of the PTSD where there is no adequate evidence to support the 
efficacy of any specific agent. It is hypothesized that M1 muscarinic 
receptor subtypes might play important role in the recall of 
negative experience. The aim of this research is to investigate both 
the behavioral and the molecular efficacy of chronic fluoxetine 
(FLU) (2.5mg/day; i.p) treatment in PTSD and also the probable 
effect of pharmacotherapy on M
1 
muscarinic receptor subtype 
expression in rats.
Materials and Methods: For experimental design random 
selection was performed to all groups; Control, Stress and 
Treatment groups. The effects of chronic FLU treatment were 
evaluated in terms of expression levels of the M1 receptors in the 
hippocampus and the frontal cortex of the rats’ brain.
Results: When the rats were subjected to the trauma reminder 
on the last day of the experiment (Day 30), the anxiety indexes 
of the stress group were found to be significantly higher than the 
control (P< 0.001). Moreover, it has been observed that chronic 
FLU treatment restored the anxiety scores in stress groups by 
lowering the anxiety indexes (P< 0.001).
Conclusion: In this study, it has been indicated that stress 
induces anxiety like behavior and reduces M1 expression in the 
hippocampus and the frontal cortex of the rats’ brain. These effects 
can be prevented by lowering the dose of chronic FLU therapy.
Keywords: Muscarinic receptors, Stress, Cat litter, Fluoxetine, 
Hippocampus, Frontal cortex
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persistent anxiety [1]. The avoidance symptom cluster is 
characterized by individuals’ efforts to avoid and emotionally 
detach or numb themselves from people, places, things, 
and activities that remind them of the traumatic event. 
Furthermore, hyperarousal, is characterized by heightened 
physiological reactivity as evidenced by exaggerated startle 
response, difficulty in concentrating, and hypervigilance. 
Recent studies show that people who have experienced 
traumatic events try to avoid remembering those events 
and also the stimuli that trigger the physical symptoms 
of anxiety [2]. In addition to this, PTSD has always been 
associated with a triggering etiologic factor, besides this it is 
considered as the only mental disorder involving an explicit 
condition [3]. The disease also has social aspects as a result 
of natural disasters or traumatic effects like terrorist attacks 
that usually affect a whole society. Therefore, it is really 
important to determine the underlying pathophysiological 
mechanisms of the disease in order to be able to develop 
better and new therapeutic drugs.
The most common types of the muscarinic receptors that 
are found in the brain are M1 type receptors and they are 
localized in the hippocampus, cerebral cortex, sympathetic 
ganglions and striatum [4,5]. A role for muscarinic receptors 
has been hypothesized in many neurodegenerative disorders. 
Although, the human disorder is not identically mimicked 
in animals, at least the researches can give an idea about 
experimental stress-induced models of depression. Exposing 
the animals to emotional or physical stress can lead to a 
depression-like behavior. In these experimental models, 
exposure of animals models to a stressor (like a predator 
threat or a predator scent) is the main aim that is commonly 
used in order to investigate the mood disorders [6]. In our 
study, the rats were exposed to a stress for 5-10 min and then 
anxiety was evaluated by an open field, elevated plus maze 
(EPM) after several days once the reminder of the trauma 
was established [7-9].
A variety of pharmacological agents are available in the 
pharmacotherapy of the PTSD. However, current evidence 
is not sufficient to support the efficacy of any specific agent 
in the prevalent symptoms of PTSD [10,11]. In this study, it 
is hypothesized that M1 muscarinic receptor subtypes might 
play an important role in the recall of negative experience. 
Changes in the expression of the M1 muscarinic receptor 
subtypes in the dorsal hippocampus and the frontal cortex of 
the rats were examined to see whether there is any alterations 
in the levels of the muscarinic receptors in those locations 
to indicate the idea that muscarinic receptor subtypes may 
play an important role in the pathophysiology of PTSD. 
Normally selective serotonin re-uptake inhibitors (SSRIs) 
are commonly used for treatment of PTSD and in this study 
cronic fluoxetine (FLU) was used as a SSRI source. FLU 
(2.5 mg/kg) was used for the chronic treatment for 30 days 
to see whether muscarinic receptor subtypes played an 
important role in the PTSD. The aim of this study was to 
investigate both the behavioral and the molecular efficacy 
of chronic FLU treatment in PTSD and also the probable 
effect of pharmacotherapy on M
1 
muscarinic receptor 
subtype expression in rats.
Materials and Methods
A. Animals and Conditions
Initially, an approval from the institutional ethical committee 
was obtained before the experimental period (approval no:, 
13.2015.Sep; Near East University Animal Experiments 
Local Ethics Committee). In this study, Wistar Albino female 
rats (n=32) weighing 220–250g and 8-10 weeks were used. 
The rats were fed ad libitum with standardized rat chow and 
water and they were habituated to the housing conditions 
in the isolation room for 10 days to become adapted to 
moisture, temperature and light. After adaptation period, 
the experiments were held under the same conditions during 
1 month period. These housing conditions were: Constant 
room temperature 21±3 °C, humidity ratio 50±5% and 12 
h light/dark cycle. As the rat models are nocturnal animals; 
all experiments were performed in the dark phase of rats’ at 
10:00 a.m.
B. Drugs and Solutions
Treatment groups received intraperitoneal (i.p) injections of 
2.5 mg/kg/day FLU (Eli Lilly, Turkey) that were suspended 
in physiological saline for a month whereas control groups 
only received physiological saline injections. The injections 
were applied 10 min before the test, and continued daily, at 
the same time of the day.
C.Cat Litter Using Predator Scent Test
For experimental design random selection was performed 
to all groups to induce stress after 10 days of acclimation 
period.
1. Control group: The rats were exposed to a clean cat 
litter at the first and the last day of the experiment.
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Additionally, during the experimental period (1 month) 
rats were only receiving physiological saline solution 
(n=8).
2. Fluoxetine (FLU) alone group: For treatment, 
continuously FLU injections were applied to rat models 
for a month. Additionally, rat models were exposed to a 
clean cat litter (n=8).
3. Stress group: In order to induce a stress condition, the 
rats were placed on 125 ml of dirty cat litter for 10 min 
in a cage (30 cm×30 cm×40 cm). The cat litter had been 
used for 2 days by the same cat and had been sifted for 
stools (n=8).
4. Stress+fluoxetine (Stress+FLU) group: The rat models 
were treated with FLU for a month. On the first day of 
the experiment a dirty cat litter was applied to the rats 
induced with PTSD model whereas at the last day of 
the experiment a clean cat litter was used as a trauma 
reminder (n=8).
For the control group, animal models were placed in an 
identical cage with clean, unused litter for 10 min [12-15]. 
The rats were exposed to a clean cat litter as a situational 
reminder on the last day of the experiment (Day 30). The 
behavioral experiments were recorded by using a video 
camera and the anxiety indexes were calculated by using 
EPM setup on the last day.
D.Elevated Plus Maze Experiments
In this study, EPM were used for experiments where rats 
were exposed to predator scent test by locating them on an 
EPM for 5 min. After that, rats were subjected to a clean 
cat litter, a situational reminder. The height of the EPM 
was 50 cm from the ground and had two open and closed 
arms (50 cm × 10 cm). Additionally, those closed arms were 
surrounded by 10 cm long walls and during experiments, 
each rat was placed in the central square of the maze facing 
towards the open arms.
E.Calculation of Anxiety Indexes (Nanxiety)
The behavioral experiments of the rats were recorded 
during 5 min using a video camera which was placed on 
top of the setup. The recordings were used to score the 
behavioral parameters. The ‘arm entry’defined the point 
when the animal manages to fit inside the EPM with four 
feet.
This information later was used to score the number 
of animals that manage to fit fully either into open or 
enclosed arms and then duration of their stay in each arm 
was recorded [16]. The anxiety indexes (N
anxiety
) were 
calculated by using A (cumulative time spent in open arms 
(s)), B (open arm entries), C (total arm entries) parameters 
and the below formula:
N
anxiety
 = 1− 1/2 [(A/300 s) + (B/C)]
F.Tissue Collection and Immunoblotting
All chemicals were purchased from Sigma (St Louis, 
MO, USA) unless indicated. Following decapitation 
of rats, firstly brains were removed and then the dorsal 
hippocampus and the frontal cortex were dissected 
according to the Rat Brain Atlas [17]. For the separation of 
the dorsal hippocampus and the frontal cortex, the slides 
in the anteroposterior planes positioned between 13.20–
11.20mm and 7.20–5.70mm, respectively, anterior to the 
interaural line. Obtained tissues were stored at −80°C 
for immunoblotting. After homogenizing procedure, the 
amount of protein contents were determined in each region 
of the brain by Lowry method [18]. Hundred micrograms 
of protein was loaded onto 12% sodium dodecyl sulfate-
polyacrylamide gels and electrophoretically transferred 
onto nitrocellulose membranes (Schleicher and Schuell, 
0.45 mm, Germany). The membranes were blocked with 
Tris buffered saline (TBS) containing 1% bovine serum 
albumin at room temperature for 1 h and incubated 
overnight at 4°C with the primary antibodies against M1, 
which was evaluated at 52 kDa (1:200 dilution, Santa Cruz, 
CA, USA). Results were standardized by using β-actin 
(Santa Cruz, CA, USA; 1:200 dilution) as the control 
protein, which was detected at 43 kDa. The densitometric 
analyses were performed with Bio-Rad Molecular Analyst 
software (free edition, www.totallab.com).
Statistical Analysis
In order to compare the behavioral effects between the 
experimental groups and the control group, Unpaired 
Student’s t-test was used for statistical analyses. For 
further evaluation, One-Way analysis of variance (One 
Way Anova) followed by Tukey’s multiple comparison 
and post hoc test were used for the remaining comparisons. 
The value for the statistical significance was accepted as 
P<0.05.
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Results
A.The Effects of Chronic Fluoxetine Treatment on 
Behavioral Parameters
When the rats were subjected to the trauma reminder on the 
last day of the experiment (Day 30), the anxiety indexes 
of the stress group were found to be significantly higher 
than the control group (Fig. 1; P< 0.001). The mean of 
the anxiety indexes of the rats for the control group was 
0.5751±0.02, FLU alone group was 0.6173±0.02, stress 
group was 0.9327±0.03, and the stress+FLU treatment 
group was 0.6734±0.03. Administration of chronic FLU 
treatment did not appreciably alter anxiety indexes in the 
control conditions prior to administration of the test. FLU 
treatment did not have any influence on anxiety indexes of 
the FLU alone group (Fig. 1). In the stress groups, it has 
been observed that FLU treatment restored the anxiety 
scores of rats by showing significantly lower values. As a 
result, Two-way analysis of variance showed that there was 
an association with the chronic FLU treatment (df = 3, F = 
46.09; P<0.0001). Moreover, The Bonferroni post hoc test 
revealed a difference between control and stress groups (t = 
4.94, P< 0.001).
B. Immunoblotting Analyses
Immunoblotting experiments were performed with 3 rats 
in each group who had higher anxiety scores. For each rat, 
the experiments were repeated twice. The frontal cortex and 
the dorsal hippocampus of the rats were homogenized and 
immunoblotting were represented as shown in Figs. 2a and 
2b.
The mean value for M1 muscarinic expression level 
which was found in the frontal cortex for the control group 
was 1.234±0.05, for the chronic FLU alone group was 
1.183±0.05 and for the stress group was 1.060±0.032. 
However, for the stress+FLU group the mean value was 
quiet different than the other groups and was 1.313±0.03. 
This difference was found to be statistically significant (P 
= 0.0044). In frontal cortex, it had been found out that M1 
receptor expression level was increased in the stress+FLU 
treatment group compared to all groups (Fig. 2a). Two-way 
analysis of variance indicated that stress+FLU group might 
play an important role in (df = 3, F = 7.702; P = 0.0074) 
producing a source of interaction. The Bonferroni post hoc 
test revealed a difference in the control group (t = 4.94, P< 
0.05).
Fig.1. The effects of chronic fluoxetine (FLU) on anxiety indexes in all groups calculated from data obtained using elevated plus maze 
experiments (n=8 per group).
*, P<0.05; ***, P<0.001 shows the difference between the stress groups and the control group. +++, P<0.001 represents the variations in treatments 
within the stress groups.
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The mean values of M1 muscarinic expression level 
in the dorsal hippocampus for the control group was 
1.670±0.03, for the FLU alone group was 1.799±0.04, for 
the stress group was 1.508±0.048, and for the stress+FLU 
group was 1.544±0.05. In the dorsal hippocampus, the level 
of M1 receptor expression was increased in the FLU alone 
group when compared to stress and stress+FLU groups. 
Two-way analysis of variance indicated that stress+FLU (df 
= 3, F = 9.621; P = 0.0036) produced a source of interaction. 
The Bonferroni post hoc test  revealed a difference in FLU 
alone group (t = 3.57, P < 0.05). FLU treatment was found 
to be effective in restoring the changes in the expression of 
M
1 
receptor of the dorsal hippocampus (Fig. 2b).
Discussion
It is known that the role of cholinergic mechanisms in stress 
has not been studied fully. Although PTSD has gained 
considerable attention in recent decades, it has not always 
been clear what constitutes adaptive versus maladaptive 
responses in traumatic stress. Therefore, understanding 
susceptibility factors that encourage persistent and invasive 
traumatic memory expression, as well as more global 
somatic PTSD symptoms, is of great scientific and practical 
value [19].
In this study, in a rat model of PTSD, the effects of chronic 
FLU treatment were evaluated in terms of expression levels 
of the M1 muscarinic receptors in the dorsal hippocampus 
and the frontal cortex of the rats brain. Muscarinic receptors 
are known to play major role in learning, storing memory 
and in posture control where the blockage of the muscarinic 
receptors leads to memory loss [20,21]. Therefore, it is 
really important to understand the underlying mechanism of 
the cholinergic muscarinic receptors in PTSD.
However, because of the species variation there are 
no animal models that can identically mimic the mood 
disorders that exist in humans. According to Cohen et al., 
studies in rat model of PTSD show that predetor scent test is 
one of the main test that is used very often to induce stress 
[22]. Therefore, in this study, for a stressor (predator scent) 
a dirty cat litter was used and a clean cat litter was used as a 
situational reminder. Like Cohen et al.[22], also in this study 
it had been found out that the anxiety index was significantly 
higher in the stress group. Our data also demonstrated that 
the cat litter test was a reproducible experiment where the 
rats were subjected to a dirty cat litter had higher anxiety 
Fig.2. The expression levels of M1 receptors in both (a) frontal cortex and (b) dorsal hippocampus after predator scent test (PST). Images 
above (a) and (b) are the representation of the membrane images as a result of the Western Blotting (n=3, each of them was duplicated). 
The M
1 
and β-actin were observed at ≅ 52 and 43 kDa, respectively.
*, P<0.05; **, P<0.01 shows the difference between stress groups and the control group
++, P<0.01 represents the variations in treatments within the stress groups.
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indexes when subjected to the clean cat litter, a situational 
reminder.
In studies where SSRI used as a treatment, it had been 
found out that there were unwanted, anxiogenic-like effects. 
Therefore, when those effects were considered, in our study 
lower dose (2.5 mg) and chronic FLU was used instead of 
high and acute FLU. As a result, anxiogenic-like effects 
were eliminated and lower dose and chronic FLU treatment 
was found to be effective in decreasing the anxiety state.
Many studies reveal that integrating cognitive and 
neurochemical responses are formed in the hippocampus 
as a result of stress. This shows that the hippocampal 
cholinergic system plays a major role in the integration of 
anxiety and the memory. In addition to this, the cortex and 
the hippocampus are known to be involved in learning and 
memory functions [23]. Therefore, in this study the frontal 
cortex and dorsal hippocampus were studied in order to 
observe the effects of stress in rats. However, in this study 
there was no experiment carried out on the learning-memory 
functions of the rats. For future researches, we thought that 
carrying out experiments on the learning-memory functions 
would be important in order to eliminate the limitations of 
this study.
In the hippocampus it had been observed that there was 
a decrease in the levels of M1 receptors as a result of the 
chronic FLU treatment in the stress groups. Many studies 
have confirmed that blockade of M1 receptors, in the dorsal 
hippocampus lower the anxiety [24,25]. Although, FLU were 
found to be effective in decreasing the anxiety state, FLU at 
10 mg/kg was found to be ineffective. Moreover, 10 mg/kg 
FLU dose was shown to increase the freezing time [26]. In 
literature, it was shown that administration of chronic FLU 
at a 5 mg/kg/ i.p reduced freezing time whereas acute FLU 
(1 mg/kg) produced the adverse effects [27]. Therefore, 
doses between 1-5mg/kg were thought to be the ideal dose 
for the treatment. The down regulation of M1 receptors 
may be counted as a natural consequence of the plasticity 
that was accomplished with effective pharmacotherapy. 
However, it should not be forgotten that there are different 
types of muscarinic receptors and cholinergic systems that 
M
1 
type receptors are associated. Therefore, in order to have 
a certain conclusion, the interaction of M1 type receptor 
with those receptors and systems should be studied as well.
Our data also revealed that the frontal cortex and the 
dorsal hippocampus recovered similarly by having similar 
results with the control group. However, there were 
variations in recovering levels of both locations.
Conclusion
In our study, it has been revealed that stress induces anxiety 
like behavior and reduces M1 expression in the dorsal 
hippocampus and these effects can be prevented by lowering 
the dose of chronical FLU therapy. Our study suggests that, 
future experimental study design should focus on alterations 
in anxiety states. Furthermore, in order to understand the 
underlying mechanisms of neurodegenerative diseases 
which are induced by stress; the relationship with other 
cholinergic receptors should be studied in more details. 
Additionally, in stress related studies, in order to analyse the 
hippocampal atrophy and amygdalar hypertrophy in terms 
of histological and morphological parameters, the number 
of studies on postmortem neuropathology on humans should 
be increased.
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